v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 81,886 $ 98,817
Restricted cash 117,759 105,000
Loans receivable at fair value 2,940,858 3,143,653
Interest and fees receivable, net 29,021 31,796
Capitalized software and other intangibles, net 127,293 139,801
Right of use assets - operating 23,186 30,448
Other assets 109,929 64,180
Total assets 3,429,932 3,613,695
Liabilities    
Secured financing 423,166 317,568
Asset-backed notes at fair value 1,958,273 2,387,674
Asset-backed borrowings at amortized cost 244,421 0
Acquisition and corporate financing 268,103 222,879
Lease liabilities 30,895 37,947
Other liabilities 63,711 100,028
Total liabilities 2,988,569 3,066,096
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at September 30, 2023 and December 31, 2022; 34,502,195 shares issued and 34,230,172 shares outstanding at September 30, 2023; 33,626,630 shares issued and 33,354,607 shares outstanding at December 31, 2022 7 7
Common stock, additional paid-in capital 579,690 547,799
Retained earnings (accumulated deficit) (132,025) 6,102
Treasury stock at cost, 272,023 shares at September 30, 2023 and December 31, 2022 (6,309) (6,309)
Total stockholders’ equity 441,363 547,599
Total liabilities and stockholders' equity $ 3,429,932 $ 3,613,695

Source